PT1487498E - Formulação tópica contendo um ciclofrutano, um veículo e um fármaco - Google Patents

Formulação tópica contendo um ciclofrutano, um veículo e um fármaco Download PDF

Info

Publication number
PT1487498E
PT1487498E PT03709792T PT03709792T PT1487498E PT 1487498 E PT1487498 E PT 1487498E PT 03709792 T PT03709792 T PT 03709792T PT 03709792 T PT03709792 T PT 03709792T PT 1487498 E PT1487498 E PT 1487498E
Authority
PT
Portugal
Prior art keywords
drug
cyclofructan
carrier
topical composition
delivery system
Prior art date
Application number
PT03709792T
Other languages
English (en)
Inventor
Lohmann Dr Dieter
Christian Schoch
Gyoergy Lajos Kis
Original Assignee
Novartis Ag
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0229019A external-priority patent/GB0229019D0/en
Priority claimed from GB0230033A external-priority patent/GB0230033D0/en
Application filed by Novartis Ag, Novartis Pharma Gmbh filed Critical Novartis Ag
Publication of PT1487498E publication Critical patent/PT1487498E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT03709792T 2002-03-18 2003-03-17 Formulação tópica contendo um ciclofrutano, um veículo e um fármaco PT1487498E (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02006085 2002-03-18
GB0229019A GB0229019D0 (en) 2002-12-12 2002-12-12 Organic compounds
GB0230033A GB0230033D0 (en) 2002-12-23 2002-12-23 Organic compounds

Publications (1)

Publication Number Publication Date
PT1487498E true PT1487498E (pt) 2009-08-19

Family

ID=28045916

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03709792T PT1487498E (pt) 2002-03-18 2003-03-17 Formulação tópica contendo um ciclofrutano, um veículo e um fármaco

Country Status (12)

Country Link
US (2) US20060216328A1 (pt)
EP (1) EP1487498B1 (pt)
JP (1) JP4523287B2 (pt)
CN (1) CN1313155C (pt)
AT (1) ATE431749T1 (pt)
AU (1) AU2003214133A1 (pt)
BR (1) BR0308486A (pt)
CA (1) CA2479351C (pt)
DE (1) DE60327693D1 (pt)
ES (1) ES2326471T3 (pt)
PT (1) PT1487498E (pt)
WO (1) WO2003077952A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050244463A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular vasculopathies
US8425929B2 (en) * 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
US8529927B2 (en) 2004-04-30 2013-09-10 Allergan, Inc. Alpha-2 agonist polymeric drug delivery systems
EP1787643A1 (en) * 2004-09-09 2007-05-23 Jimenez Bayardo, Arturo Implants and microspheres for the sustained release of drugs for ophthalmic use and preparation methods thereof
US7931909B2 (en) 2005-05-10 2011-04-26 Allergan, Inc. Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
CA2850858A1 (en) 2005-09-16 2007-04-05 Allergan, Inc. Compositions and methods for the intraocular transport of therapeutic agents
AR059928A1 (es) 2006-09-29 2008-05-07 Johnson & Johnson Vision Care Metodos y dispositivos oftalmicos usados en el tratamiento de alergias oculares
US20090036404A1 (en) * 2007-08-02 2009-02-05 Macleod Steven K Ophthalmic compositions comprising a carboxyl-modified fructan or a salt thereof
JP5394645B2 (ja) * 2008-03-11 2014-01-22 公益財団法人野口研究所 糖結合型スピロクラウンエーテル誘導体
US9877973B2 (en) 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US10064819B2 (en) 2008-05-12 2018-09-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US9095404B2 (en) 2008-05-12 2015-08-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
JP5591226B2 (ja) 2008-05-12 2014-09-17 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション 眼内薬物送達装置および関連する方法
US9095506B2 (en) 2008-11-17 2015-08-04 Allergan, Inc. Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
CN102596097B (zh) 2009-06-03 2015-05-20 弗赛特实验室有限责任公司 一种眼插入件
EP2443127A4 (en) * 2009-06-17 2012-10-24 Univ Texas COMPOSITIONS AND METHODS FOR CYCLOFRUCTANES AS SEPARATION AGENTS
KR101769637B1 (ko) 2009-11-09 2017-08-18 알러간, 인코포레이티드 모발 성장을 촉진하기 위한 조성물 및 방법
US20110142889A1 (en) * 2009-12-16 2011-06-16 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
CN103917202B (zh) 2011-09-14 2016-06-29 弗赛特影像5股份有限公司 眼插入件装置和方法
US9827250B2 (en) * 2012-07-31 2017-11-28 Johnson & Johnson Vision Care, Inc. Lens incorporating myopia control optics and muscarinic agents
EP2911623B1 (en) 2012-10-26 2019-08-14 Forsight Vision5, Inc. Ophthalmic system for sustained release of drug to eye
BR112015019546A2 (pt) 2013-02-15 2017-07-18 Allergan Inc implante de distribuição de drogas prolongado
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
CN106074361B (zh) * 2016-07-14 2018-10-19 何伟 一种抗眼内炎症植入剂及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1491272A (en) * 1975-09-10 1977-11-09 Lingner & Fischer Gmbh Polymer adhesive compositions containing gelling agents
JPH05310805A (ja) * 1992-05-06 1993-11-22 Mitsubishi Kasei Corp アシル化環状イヌロオリゴ糖およびその製造法
JPH06141879A (ja) * 1992-11-05 1994-05-24 Mitsubishi Kasei Corp 環状イヌロオリゴ糖の精製方法
JPH06141856A (ja) * 1992-11-05 1994-05-24 Mitsubishi Kasei Corp 環状イヌロオリゴ糖及び環状イヌロオリゴ糖生成酵素の製造方法
JPH06298807A (ja) * 1993-02-19 1994-10-25 Mitsubishi Kasei Corp 新規な環状イヌロオリゴ糖誘導体
CA2120197A1 (en) * 1993-04-02 1994-10-03 Kenji Endo Stable aqueous dispersions containing liposomes
US5464650A (en) * 1993-04-26 1995-11-07 Medtronic, Inc. Intravascular stent and method
JPH0753347A (ja) * 1993-08-19 1995-02-28 Mitsubishi Chem Corp 皮膚化粧料
JPH07274990A (ja) * 1994-04-15 1995-10-24 Mitsubishi Kasei Eng Co 環状イヌロオリゴ糖の精製方法
TW434023B (en) * 1995-09-18 2001-05-16 Novartis Ag Preserved ophthalmic composition
US5980551A (en) * 1997-02-07 1999-11-09 Endovasc Ltd., Inc. Composition and method for making a biodegradable drug delivery stent
US5972363A (en) * 1997-04-11 1999-10-26 Rohm And Haas Company Use of an encapsulated bioactive composition
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
CA2390952C (en) * 2001-07-02 2006-07-11 Rohm And Haas Company Compositions and process for retaining active ingredients comprising networked structured polymers
GB0315745D0 (en) * 2003-07-04 2003-08-13 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
US20100160437A1 (en) 2010-06-24
CN1642578A (zh) 2005-07-20
BR0308486A (pt) 2005-01-18
CN1313155C (zh) 2007-05-02
JP4523287B2 (ja) 2010-08-11
EP1487498A1 (en) 2004-12-22
US20060216328A1 (en) 2006-09-28
AU2003214133A1 (en) 2003-09-29
WO2003077952A1 (en) 2003-09-25
CA2479351C (en) 2012-05-15
CA2479351A1 (en) 2003-09-25
ES2326471T3 (es) 2009-10-13
ATE431749T1 (de) 2009-06-15
JP2005523299A (ja) 2005-08-04
DE60327693D1 (de) 2009-07-02
EP1487498B1 (en) 2009-05-20

Similar Documents

Publication Publication Date Title
PT1487498E (pt) Formulação tópica contendo um ciclofrutano, um veículo e um fármaco
WO2003011226A3 (en) Products and drug delivery vehicles
AU2003228666A1 (en) Lapachone delivery systems, compositions and uses related thereto
GB2421689B (en) Drug delivery system
AU2002244133A1 (en) Delivery systems for mycotechnologies, mycofiltration and mycoremediation
EP1370023A4 (en) INHALTSABLIEFERSYSTEM
AU2003231781A1 (en) Content delivery system
AU2003263062A1 (en) Secure content delivery system
HK1149574A1 (en) Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes
HK1064920A1 (en) Enhanced drug delivery in transdermal systems
AP2002002558A0 (en) Pharmaceutical compositions containing polymer and drug assemblies.
HK1036976A1 (en) Benzimidazoles, production thereof and use thereofas medicaments.
AU2003241469A1 (en) Personal care articles with fragrance delivery system
ZA200407794B (en) Novel biomaterials, their preparation and use.
PL376169A1 (en) Drug delivery system
AU2003212962A8 (en) Transdermal drug delivery systems
MY121519A (en) Dosing regimens for lasofoxifene
AU2003228995A8 (en) Content delivery system
AU2003232488A1 (en) Flat film conductors comprising thermoplastic polyurethane
PL376130A1 (en) Controlled releases system containing temozolomide
AU2003272260A8 (en) Verifiable absorption drug delivery form based on cyclodextrins
ZA200409726B (en) Monocompartment osmotic controlled drug delivery system.
AU2003241783A1 (en) Article delivery system
AU2003285550A1 (en) Drug delivery system
MXPA04002104A (es) Anticuerpos contra caspasa-8, su preparacion y uso.